Coldstream Capital Management’s PLDT PHI Stock Holding History

Coldstream Capital Management’s Portfolio PHI Stock Details PHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,285	Closed	-$28.1K	–	2718
2025 Q1	$28.1K	Buy	+1,285	New	+$29.7K	﹤0.01%	1965

Other funds holding PHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Coldstream Capital Management's PHI Position: Q2 2025 in Review

Coldstream Capital Management sold out of PLDT (PHI) in Q2 2025, closing a stake of 1,285 shares — an estimated $28.1K sold.

Coldstream Capital Management first reported a position in PHI in Q1 2025 and held it in 1 quarter. The position peaked at $28.1K in Q1 2025. 86 funds tracked by Wall St. Rank hold PHI as of Q2 2025.

Coldstream Capital Management reported no remaining PLDT position as of Q2 2025 after selling out during the quarter.
Coldstream Capital Management sold 1,285 PLDT shares in Q2 2025, an estimated $28.1K.
Coldstream Capital Management first reported a position in PLDT in Q1 2025 and held it in 1 quarter.
Coldstream Capital Management's PLDT position peaked at $28.1K in Q1 2025.
86 funds tracked by Wall St. Rank held PLDT as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.